185 related articles for article (PubMed ID: 38507590)
1. Breaking Physical Barrier of Fibrotic Breast Cancer for Photodynamic Immunotherapy by Remodeling Tumor Extracellular Matrix and Reprogramming Cancer-Associated Fibroblasts.
Qiu ZW; Zhong YT; Lu ZM; Yan N; Kong RJ; Huang JQ; Li ZF; Nie JM; Li R; Cheng H
ACS Nano; 2024 Apr; 18(13):9713-9735. PubMed ID: 38507590
[TBL] [Abstract][Full Text] [Related]
2. Antifibrotic therapy to normalize the tumor microenvironment.
Hauge A; Rofstad EK
J Transl Med; 2020 May; 18(1):207. PubMed ID: 32434573
[TBL] [Abstract][Full Text] [Related]
3. Dendritic Polymer-Based Nanomedicines Remodel the Tumor Stroma: Improve Drug Penetration and Enhance Antitumor Immune Response.
Zhang Y; Fang Z; Pan D; Li Y; Zhou J; Chen H; Li Z; Zhu M; Li C; Qin L; Ren X; Gong Q; Luo K
Adv Mater; 2024 Jun; 36(25):e2401304. PubMed ID: 38469918
[TBL] [Abstract][Full Text] [Related]
4. Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling.
Tang X; Hou Y; Yang G; Wang X; Tang S; Du YE; Yang L; Yu T; Zhang H; Zhou M; Wen S; Xu L; Liu M
Cell Death Differ; 2016 Jan; 23(1):132-45. PubMed ID: 26068592
[TBL] [Abstract][Full Text] [Related]
5. Cancer-Associated Fibroblasts and Extracellular Matrix: Therapeutical Strategies for Modulating the Cholangiocarcinoma Microenvironment.
Minini M; Fouassier L
Curr Oncol; 2023 Apr; 30(4):4185-4196. PubMed ID: 37185432
[TBL] [Abstract][Full Text] [Related]
6. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
7. Safe engineering of cancer-associated fibroblasts enhances checkpoint blockade immunotherapy.
Geng S; Xiang T; Zhang Y; Guo P; Zhang H; Zhang Z; Gu M; Zhang K; Song H; Shi J; Liu J
J Control Release; 2023 Apr; 356():272-287. PubMed ID: 36870541
[TBL] [Abstract][Full Text] [Related]
8. Cancer associated fibroblasts: is the force the path to the dark side?
Barbazán J; Matic Vignjevic D
Curr Opin Cell Biol; 2019 Feb; 56():71-79. PubMed ID: 30308331
[TBL] [Abstract][Full Text] [Related]
9. Construction of a Matrix Cancer-Associated Fibroblast Signature Gene-Based Risk Prognostic Signature for Directing Immunotherapy in Patients with Breast Cancer Using Single-Cell Analysis and Machine Learning.
Huang B; Chen Q; Ye Z; Zeng L; Huang C; Xie Y; Zhang R; Shen H
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685980
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis.
Erdogan B; Webb DJ
Biochem Soc Trans; 2017 Feb; 45(1):229-236. PubMed ID: 28202677
[TBL] [Abstract][Full Text] [Related]
11. Strategy of targeting the tumor microenvironment via inhibition of fibroblast/fibrosis remodeling new era to cancer chemo-immunotherapy resistance.
Tajaldini M; Poorkhani A; Amiriani T; Amiriani A; Javid H; Aref P; Ahmadi F; Sadani S; Khori V
Eur J Pharmacol; 2023 Oct; 957():175991. PubMed ID: 37619785
[TBL] [Abstract][Full Text] [Related]
12. Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy.
Wang X; Zhang W; Zeng S; Wang L; Wang B
Acta Biomater; 2024 Feb; 175():262-278. PubMed ID: 38141933
[TBL] [Abstract][Full Text] [Related]
13. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis.
Zhang W; Wang J; Liu C; Li Y; Sun C; Wu J; Wu Q
J Transl Med; 2023 Nov; 21(1):827. PubMed ID: 37978384
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions.
Wang K; Wu F; Seo BR; Fischbach C; Chen W; Hsu L; Gourdon D
Matrix Biol; 2017 Jul; 60-61():86-95. PubMed ID: 27503584
[TBL] [Abstract][Full Text] [Related]
16. Stroma-targeting strategies in pancreatic cancer: a double-edged sword.
Liu X; Iovanna J; Santofimia-Castaño P
J Physiol Biochem; 2023 Feb; 79(1):213-222. PubMed ID: 36580230
[TBL] [Abstract][Full Text] [Related]
17. Targeting integrin α5 in fibroblasts potentiates colorectal cancer response to PD-L1 blockade by affecting extracellular-matrix deposition.
Lu L; Gao Y; Huang D; Liu H; Yin D; Li M; Zheng J; Wang S; Wu W; Zhao L; Bi D; Zhang Y; Song F; Xie R; Wang J; Qin H; Wei Q
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040421
[TBL] [Abstract][Full Text] [Related]
18. More than a syllable in fib-ROS-is: The role of ROS on the fibrotic extracellular matrix and on cellular contacts.
Grosche J; Meißner J; Eble JA
Mol Aspects Med; 2018 Oct; 63():30-46. PubMed ID: 29596842
[TBL] [Abstract][Full Text] [Related]
19. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
20. Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models.
Hu J; Lazar AJ; Ingram D; Wang WL; Zhang W; Jia Z; Ragoonanan D; Wang J; Xia X; Mahadeo K; Gorlick R; Li S
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38199607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]